S&P 500   5,098.69 (+0.23%)
DOW   39,231.67 (+0.42%)
QQQ   438.45 (+0.09%)
AAPL   183.43 (-0.51%)
MSFT   412.31 (+0.16%)
META   488.38 (+0.46%)
GOOGL   144.11 (+0.01%)
AMZN   174.86 (+0.16%)
TSLA   194.54 (-1.45%)
NVDA   797.93 (+1.60%)
NIO   5.39 (-7.86%)
AMD   177.50 (-2.40%)
BABA   75.81 (-0.41%)
T   16.73 (+0.84%)
F   12.12 (+0.00%)
MU   85.49 (-0.49%)
CGC   3.21 (-4.75%)
GE   153.02 (+0.89%)
DIS   106.29 (-1.25%)
AMC   4.30 (-2.71%)
PFE   27.97 (+1.52%)
PYPL   58.96 (+1.05%)
XOM   103.56 (-1.15%)
S&P 500   5,098.69 (+0.23%)
DOW   39,231.67 (+0.42%)
QQQ   438.45 (+0.09%)
AAPL   183.43 (-0.51%)
MSFT   412.31 (+0.16%)
META   488.38 (+0.46%)
GOOGL   144.11 (+0.01%)
AMZN   174.86 (+0.16%)
TSLA   194.54 (-1.45%)
NVDA   797.93 (+1.60%)
NIO   5.39 (-7.86%)
AMD   177.50 (-2.40%)
BABA   75.81 (-0.41%)
T   16.73 (+0.84%)
F   12.12 (+0.00%)
MU   85.49 (-0.49%)
CGC   3.21 (-4.75%)
GE   153.02 (+0.89%)
DIS   106.29 (-1.25%)
AMC   4.30 (-2.71%)
PFE   27.97 (+1.52%)
PYPL   58.96 (+1.05%)
XOM   103.56 (-1.15%)
S&P 500   5,098.69 (+0.23%)
DOW   39,231.67 (+0.42%)
QQQ   438.45 (+0.09%)
AAPL   183.43 (-0.51%)
MSFT   412.31 (+0.16%)
META   488.38 (+0.46%)
GOOGL   144.11 (+0.01%)
AMZN   174.86 (+0.16%)
TSLA   194.54 (-1.45%)
NVDA   797.93 (+1.60%)
NIO   5.39 (-7.86%)
AMD   177.50 (-2.40%)
BABA   75.81 (-0.41%)
T   16.73 (+0.84%)
F   12.12 (+0.00%)
MU   85.49 (-0.49%)
CGC   3.21 (-4.75%)
GE   153.02 (+0.89%)
DIS   106.29 (-1.25%)
AMC   4.30 (-2.71%)
PFE   27.97 (+1.52%)
PYPL   58.96 (+1.05%)
XOM   103.56 (-1.15%)
S&P 500   5,098.69 (+0.23%)
DOW   39,231.67 (+0.42%)
QQQ   438.45 (+0.09%)
AAPL   183.43 (-0.51%)
MSFT   412.31 (+0.16%)
META   488.38 (+0.46%)
GOOGL   144.11 (+0.01%)
AMZN   174.86 (+0.16%)
TSLA   194.54 (-1.45%)
NVDA   797.93 (+1.60%)
NIO   5.39 (-7.86%)
AMD   177.50 (-2.40%)
BABA   75.81 (-0.41%)
T   16.73 (+0.84%)
F   12.12 (+0.00%)
MU   85.49 (-0.49%)
CGC   3.21 (-4.75%)
GE   153.02 (+0.89%)
DIS   106.29 (-1.25%)
AMC   4.30 (-2.71%)
PFE   27.97 (+1.52%)
PYPL   58.96 (+1.05%)
XOM   103.56 (-1.15%)

Surface Oncology (SURF) SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.

Recent Surface Oncology SEC Filings

DateFilerForm TypeView
09/15/2023
6:27 PM
Surface Oncology (Filer)
Form 15-12G
09/12/2023
11:15 PM
Surface Oncology (Filer)
Form EFFECT
09/12/2023
11:15 PM
Surface Oncology (Filer)
Form EFFECT
09/08/2023
8:26 AM
Nasdaq Stock Market LLC (Filed by)
Surface Oncology (Subject)
Form 25-NSE
09/08/2023
8:21 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:18 PM
Surface Oncology (Filer)
Form DEFA14A
08/30/2023
3:31 PM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2023
3:32 PM
Surface Oncology (Subject)
Form 425
08/30/2023
3:34 PM
Surface Oncology (Filer)
Form DEFA14A
08/11/2023
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
7:00 PM
ONEILL ALISON (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
7:00 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
7:00 PM
Adams Chandra (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2023
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
6:06 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2023
7:00 AM
ADAR1 Partners, LP (Filed by)
Surface Oncology (Subject)
Form SC 13G
07/12/2023
4:05 PM
Surface Oncology (Subject)
Form 425
07/12/2023
4:08 PM
Surface Oncology (Subject)
Form 425
07/07/2023
8:39 PM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
3:01 PM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:19 PM
Surface Oncology (Subject)
Form 425
06/16/2023
4:21 PM
Surface Oncology (Subject)
Form 425
06/16/2023
4:11 PM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
06/16/2023
4:12 PM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
06/16/2023
4:14 PM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
06/16/2023
4:14 PM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
06/16/2023
4:16 PM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
06/16/2023
4:17 PM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
06/16/2023
3:46 PM
Surface Oncology (Subject)
Form 425
06/16/2023
3:37 PM
Surface Oncology (Subject)
Form 425
06/16/2023
3:39 PM
Surface Oncology (Subject)
Form 425
06/16/2023
3:40 PM
Surface Oncology (Subject)
Form 425
06/16/2023
3:43 PM
Surface Oncology (Subject)
Form 425
06/16/2023
3:35 PM
Surface Oncology (Subject)
Form 425
06/16/2023
7:08 AM
Coherus BioSciences, Inc. (Subject)
Surface Oncology (Filed by)
Form 425
06/16/2023
6:45 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
6:09 AM
Coherus BioSciences, Inc. (Filed by)
Surface Oncology (Subject)
Form 425
05/04/2023
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
6:06 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2023
3:31 PM
Surface Oncology (Filer)
Form 10-K/A
03/09/2023
6:01 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2023
6:05 AM
Surface Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2023
6:11 AM
Surface Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2023
7:00 PM
Palombella Vito J. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:00 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:00 PM
ONEILL ALISON (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:00 PM
Adams Chandra (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
7:00 PM
RATH HENRY C. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SURF) was last updated on 2/23/2024 by MarketBeat.com Staff